Cancer nursing. 2025 May-Jun;48(3):157-158. doi: 10.1097/NCC.0000000000001485 Q12.42024

Time Matters: Addressing the Hidden Toxicity in Cancer Care and Placing Emphasis Where It Belongs

时间攸关：正视抗癌疗法的隐性毒副作用，并采取有效应对措施 翻译改进

作者单位 +展开

DOI: 10.1097/NCC.0000000000001485 PMID: 40249665

摘要 中英对照阅读

Copyright © Cancer nursing. 中文内容为AI机器翻译，仅供参考！

相关内容

• The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic

  新冠肺炎疫情下的常规肿瘤毒性管理的远程化转型

  Marika Rasschaert et al.

  British journal of cancer. 2021 Apr;124(8):1366-1372.

• Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care

  辅助曲妥珠单抗临床试验中的交叉问题：避免毒副反应对患者的伤害

  Jordan E Tuia

  American journal of clinical oncology. 2022 Oct 1;45(10):438-441.

• Management of Other Toxicities

  其他毒性管理

  Hermann Einsele

  .

• Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study

  卡铂脱敏治疗复发性上皮卵巢癌的毒性和疗效：一项真实世界研究

  Nail Paksoy et al.

  Medicine. 2022 Nov 11;101(45):e31726.

• American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States

  关于美国嵌合抗原受体T细胞治疗管理实践的调查报告

  Zahra Mahmoudjafari et al.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Jan;25(1):26-33.

• Management of rash and other toxicities in patients treated with epidermal growth factor receptor-targeted agents

  表皮生长因子受体靶向药物相关性皮疹等毒性的处理措施

  Jay Rhee et al.

  Clinical colorectal cancer. 2005 Nov:5 Suppl 2:S101-6.

• Can monitoring asparaginase activity help us to manage toxicity in pediatric acute lymphoblastic leukemia?

  检测天冬酰胺酶活性能否帮助我们防治儿童急性淋巴细胞白血病患者的毒副反应？

  Carmen Hernández-Marqués et al.

  Leukemia & lymphoma. 2020 Apr;61(4):990-992.

• Toxicity of Chimeric Antigen Receptor T Cells and its Management

  嵌合抗原受体T细胞的毒性作用及其管理措施

  Kitsada Wudhikarn et al.

  Blood cell therapy. 2021 Oct 14;4(Spec Edition):S1-S7.